Table VII.
Plasma KRAS mutation site
|
||||
---|---|---|---|---|
Patient | Gender | Age | Preoperatively | Postoperatively |
1 | Female | 71 | Gly13Asp | Wild-type |
2 | Female | 81 | Gly12Val | Wild-type |
4 | Male | 72 | Gly12Ser | Wild-type |
5 | Female | 51 | Gly13Asp | Wild-type |
6 | Female | 78 | Gly12Val | Wild-type |